IL4 and myocarditis: While no studies have as yet identified genetic risk biomarkers for the development of myocarditis, cardiac symptoms or troponin release injury post immunization, other adverse events or systemic symptoms have been linked to genetic polymorphism in the cytokine gene for IL4 [26].